Completed NCT01214135
This study is completed in Sweden. It is testing Use of Seroquel Extended Release (XR) and Immediate Release (IR) for schizophrenia.
Multiple locations, including Falköping Schizophrenia Other From 18 Years to 65 Years
Countries Sweden
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT06699940
This study is completed in the United States. It is testing neuroStar® Advanced Therapy for Anxiety.
In Malvern Anxiety Device i A study involving a tool, app, wearable, test, or medical device. From 12 Years to 21 Years
Countries United States
Sponsor Neuronetics
Condition Anxiety Terminated NCT02479906
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Los Angeles PTSD Device From 22 Years to 68 Years
Countries United States, Canada, Israel
Sponsor Brainsway
Condition PTSD Terminated NCT01480232
This summary needs review. Please check the official study record and contact the research team for details.
In Boston Addiction Behavioral From 18 Years to 65 Years
Countries United States
Sponsor A. Eden Evins
Condition Addiction Completed NCT00566449
This study exists to compare options and see whether the medication JNJ-31001074 offers something meaningfully different. Researchers are trying to understand whether the medication JNJ-31001074 can improve attention, thinking, or day-to-day functioning.
Multiple locations, including Irvine ADHD Drug i A study involving a medication or substance. From 18 Years to 64 Years
Countries United States
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition ADHD Completed NCT00326391
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed ADHD Drug From 18 Years to 65 Years
Countries
Sponsor McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Condition ADHD Completed NCT01947803
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Baoding Schizophrenia Drug From 18 Years to 65 Years
Countries China
Sponsor Xian-Janssen Pharmaceutical Ltd.
Condition Schizophrenia Completed NCT00528697
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock ADHD Drug From 6 Years to 12 Years
Countries United States
Sponsor AbbVie (prior sponsor, Abbott)
Condition ADHD Completed NCT02432703
This study is completed in the United States, in Australia, and in Canada. It is testing JNJ-42165279 for anxiety.
Multiple locations, including La Jolla Anxiety Drug From 18 Years to 64 Years
Countries United States, Australia, Canada
Sponsor Janssen Research & Development, LLC
Condition Anxiety Terminated NCT01114698
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Arcadia Depression Behavioral From 18 Years to 65 Years
Countries United States
Sponsor Janssen Research & Development, LLC
Condition Depression Withdrawn NCT01685151
This study was withdrawn. It is testing ramelteon Tablets for Bipolarity.
Location not clearly listed Bipolarity Drug From 18 Years to 75 Years
Countries
Sponsor Takeda
Condition Bipolarity Completed NCT00796081
This study is completed. It is testing ER OROS Paliperidone for schizophrenia.
Location not clearly listed Schizophrenia Drug From 10 Years to 17 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia